Question-based Drug Development for psilocybin
Lancet Psychiatry
.
2016 Sep;3(9):806-7.
doi: 10.1016/S2215-0366(16)30214-0.
Authors
Francis M Dijkstra
1
,
Gabriel E Jacobs
2
,
Adam F Cohen
3
Affiliations
1
Centre for Human Drug Research, Zernikedreef 8, 2333 CL Leiden, The Netherlands. Electronic address: FDijkstra@chdr.nl.
2
Centre for Human Drug Research, Zernikedreef 8, 2333 CL Leiden, The Netherlands; Leiden University Medical Centre, Leiden, Netherlands.
3
Centre for Human Drug Research, Zernikedreef 8, 2333 CL Leiden, The Netherlands.
PMID:
27568265
DOI:
10.1016/S2215-0366(16)30214-0
No abstract available
Publication types
Letter
Comment
MeSH terms
Depression
Drug Development
Feasibility Studies
Hallucinogens*
Psilocybin*
Substances
Hallucinogens
Psilocybin